Skip to content

The Lone Star Bleeding Disorders Foundation is pleased to announce the Matthew Thomas Memorial Academic Scholarship Fund. 

To serve the bleeding disorders community of South Texas, the Lone Star BDF will award up to four $2,500 Academic Scholarships for the 2023-2024 school year.

 

To be eligible for the Matthew Thomas Memorial Academic Scholarship, students must be directly affected with an inherited bleeding disorder, or an immediate family member of someone with a bleeding disorder (parent/guardian/sibling/child of) and pursuing a degree from an accredited post-secondary University, College, or Junior College.  They do not have to be first-year students.  This scholarship is open to anyone pursuing a degree.

 

Along with a completed scholarship application, qualified applicants must provide documentation of post-secondary enrollment, high school/college transcripts, letters of recommendation, and personal essay.  A person may only receive a scholarship once.

 

Download PDF Application 

 

Matthew Thomas Memorial Academic Scholarship Checklist

Submit completed application and requested documents on our website www.lonestarbleedingdisorders.org under the Resources Tab by April 30th, 2023

You may also send printed application and documents, postmarked by April 30th, 2023 to

 

Lone Star Bleeding Disorders Foundation

ATTN:  Scholarship Committee

5600 Northwest Central Suite 140

Houston, TX 77092

 

Or email to Heidi Hensley

 

Be sure to include:
  •  
    • Completed Application
    • High-school or college transcripts
    • Documentation of post-secondary enrollment
    • Personal Essay
    • Two letters of recommendation

News from HFA

  • Word from Washington: August 2023

    Advocates are responding to yet another payer-side, cost-saving scheme that harms patient access to medicine. The latest version, the so-called “alternative funding program” (AFP), is a shady strategy pitched to employers that promises to lower health plan spending on specialty drugs such as bleeding disorder products and other expensive medicines. AFP vendors advise employer health The post Word from Washington: August 2023 appeared first on Hemophilia Federation of America.

  • UPDATE: Takeda to Voluntarily Replace Certain BAXJECT® II Reconstitution Devices

    UPDATE as of 8/28/2023 Takeda, in agreement with the U.S. Food and Drug Administration (FDA), has decided to voluntarily replace BAXJECT® II reconstitution devices produced by Baxter between October 2021 and January 2022 co-packaged for use in conjunction with RECOMBINATE™ [Antihemophilic Factor (Recombinant)] and RIXUBIS® [Coagulation [Factor IX (Recombinant)]. Takeda has received reports of white The post UPDATE: Takeda to Voluntarily Replace Certain BAXJECT® II Reconstitution Devices appeared first on Hemophilia Federation of America.

  • Dear Addy: In-District Legislative Meetings

    Dear Addy, With Congress in recess, how can I continue to participate in legislative advocacy? Signed, Bleeding Disorders Advocate Dear Bleeding Disorders Advocate, Every August, the United States Congress embarks on a recess, temporarily adjourning its legislative business and allowing members to return to their home states and districts. The August recess tradition serves as The post Dear Addy: In-District Legislative Meetings appeared first on Hemophilia Federation of America.

  • Word from Washington: July 2023

    July saw mounting coverage losses from the national Medicaid unwinding. As of July 28, nearly four million people have been disenrolled from Medicaid since redeterminations began in April 2023. Three-quarters of that total lost coverage for procedural reasons, i.e., paperwork, and may still be eligible for Medicaid. In response to this dismaying track record:  Also The post Word from Washington: July 2023 appeared first on Hemophilia Federation of America.

  • Blog: Intern Introspective #7

    It feels incredibly surreal to think about the fact that this is my final week at HFA this summer, and that in less than a week I will no longer be exploring D.C. and will instead be back home in San Diego. The past ten weeks here in Washington, D.C. with HFA have been an The post Blog: Intern Introspective #7 appeared first on Hemophilia Federation of America.